132 related articles for article (PubMed ID: 17674361)
21. Discovery of frequent homozygous deletions in chromosome 3p21.3 LUCA and AP20 regions in renal, lung and breast carcinomas.
Senchenko VN; Liu J; Loginov W; Bazov I; Angeloni D; Seryogin Y; Ermilova V; Kazubskaya T; Garkavtseva R; Zabarovska VI; Kashuba VI; Kisselev LL; Minna JD; Lerman MI; Klein G; Braga EA; Zabarovsky ER
Oncogene; 2004 Jul; 23(34):5719-28. PubMed ID: 15208675
[TBL] [Abstract][Full Text] [Related]
22. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.
Dammann R; Li C; Yoon JH; Chin PL; Bates S; Pfeifer GP
Nat Genet; 2000 Jul; 25(3):315-9. PubMed ID: 10888881
[TBL] [Abstract][Full Text] [Related]
23. miR-101 DNA copy loss is a prominent subtype specific event in lung cancer.
Thu KL; Chari R; Lockwood WW; Lam S; Lam WL
J Thorac Oncol; 2011 Sep; 6(9):1594-8. PubMed ID: 21849855
[TBL] [Abstract][Full Text] [Related]
24. Association of p16 homozygous deletions with clinicopathologic characteristics and EGFR/KRAS/p53 mutations in lung adenocarcinoma.
Iwakawa R; Kohno T; Anami Y; Noguchi M; Suzuki K; Matsuno Y; Mishima K; Nishikawa R; Tashiro F; Yokota J
Clin Cancer Res; 2008 Jun; 14(12):3746-53. PubMed ID: 18559592
[TBL] [Abstract][Full Text] [Related]
25. Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers.
Nagatake M; Takagi Y; Osada H; Uchida K; Mitsudomi T; Saji S; Shimokata K; Takahashi T; Takahashi T
Cancer Res; 1996 Jun; 56(12):2718-20. PubMed ID: 8665501
[TBL] [Abstract][Full Text] [Related]
26. Multiple mechanisms of p16INK4A inactivation in non-small cell lung cancer cell lines.
Shapiro GI; Park JE; Edwards CD; Mao L; Merlo A; Sidransky D; Ewen ME; Rollins BJ
Cancer Res; 1995 Dec; 55(24):6200-9. PubMed ID: 8521414
[TBL] [Abstract][Full Text] [Related]
27. Homozygous deletions and chromosome amplifications in human lung carcinomas revealed by single nucleotide polymorphism array analysis.
Zhao X; Weir BA; LaFramboise T; Lin M; Beroukhim R; Garraway L; Beheshti J; Lee JC; Naoki K; Richards WG; Sugarbaker D; Chen F; Rubin MA; Jänne PA; Girard L; Minna J; Christiani D; Li C; Sellers WR; Meyerson M
Cancer Res; 2005 Jul; 65(13):5561-70. PubMed ID: 15994928
[TBL] [Abstract][Full Text] [Related]
28. Detecting homozygous deletions in the CDKN2A(p16(INK4a))/ARF(p14(ARF)) gene in urinary bladder cancer using real-time quantitative PCR.
Berggren P; Kumar R; Sakano S; Hemminki L; Wada T; Steineck G; Adolfsson J; Larsson P; Norming U; Wijkström H; Hemminki K
Clin Cancer Res; 2003 Jan; 9(1):235-42. PubMed ID: 12538475
[TBL] [Abstract][Full Text] [Related]
29. [p16/CDKN2/MTS1 gene abnormality in lung cancer].
Ohno A
Nihon Rinsho; 1996 Feb; 54(2):503-6. PubMed ID: 8838105
[TBL] [Abstract][Full Text] [Related]
30. Transcript map and complete genomic sequence for the 310 kb region of minimal allele loss on chromosome segment 11p15.5 in non-small-cell lung cancer.
Zhao B; Bepler G
Oncogene; 2001 Dec; 20(56):8154-64. PubMed ID: 11781830
[TBL] [Abstract][Full Text] [Related]
31. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
[TBL] [Abstract][Full Text] [Related]
32. Homozygous deletion of p16INK4a and tobacco carcinogen exposure in nonsmall cell lung cancer.
Kraunz KS; Nelson HH; Lemos M; Godleski JJ; Wiencke JK; Kelsey KT
Int J Cancer; 2006 Mar; 118(6):1364-9. PubMed ID: 16184554
[TBL] [Abstract][Full Text] [Related]
33. Homozygous deletions of human chromosome 3p in lung tumors.
Todd S; Franklin WA; Varella-Garcia M; Kennedy T; Hilliker CE; Hahner L; Anderson M; Wiest JS; Drabkin HA; Gemmill RM
Cancer Res; 1997 Apr; 57(7):1344-52. PubMed ID: 9102223
[TBL] [Abstract][Full Text] [Related]
34. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification.
Kim YH; Girard L; Giacomini CP; Wang P; Hernandez-Boussard T; Tibshirani R; Minna JD; Pollack JR
Oncogene; 2006 Jan; 25(1):130-8. PubMed ID: 16116477
[TBL] [Abstract][Full Text] [Related]
35. Identification of three distinct tumor suppressor loci on the short arm of chromosome 9 in small cell lung cancer.
Kim SK; Ro JY; Kemp BL; Lee JS; Kwon TJ; Fong KM; Sekido Y; Minna JD; Hong WK; Mao L
Cancer Res; 1997 Feb; 57(3):400-3. PubMed ID: 9012464
[TBL] [Abstract][Full Text] [Related]
36. Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer.
Modi S; Kubo A; Oie H; Coxon AB; Rehmatulla A; Kaye FJ
Oncogene; 2000 Sep; 19(40):4632-9. PubMed ID: 11030152
[TBL] [Abstract][Full Text] [Related]
37. Numerical abnormalities of chromosome 9 and p16CDKN2A gene deletion detected by FISH in non-small cell lung cancer.
Panani AD; Maliaga K; Babanaraki A; Bellenis I
Anticancer Res; 2009 Nov; 29(11):4483-7. PubMed ID: 20032395
[TBL] [Abstract][Full Text] [Related]
38. Aberrant upregulation of a novel integrin alpha subunit gene at 3p21.3 in small cell lung cancer.
Hibi K; Yamakawa K; Ueda R; Horio Y; Murata Y; Tamari M; Uchida K; Takahashi T; Nakamura Y; Takahashi T
Oncogene; 1994 Feb; 9(2):611-9. PubMed ID: 8290272
[TBL] [Abstract][Full Text] [Related]
39. Mutations in the p16INK4/MTS1/CDKN2, p15INK4B/MTS2, and p18 genes in primary and metastatic lung cancer.
Okamoto A; Hussain SP; Hagiwara K; Spillare EA; Rusin MR; Demetrick DJ; Serrano M; Hannon GJ; Shiseki M; Zariwala M
Cancer Res; 1995 Apr; 55(7):1448-51. PubMed ID: 7882351
[TBL] [Abstract][Full Text] [Related]
40. Mapping of homozygous deletions in verified esophageal adenocarcinoma cell lines and xenografts.
Boonstra JJ; van Marion R; Douben HJ; Lanchbury JS; Timms KM; Abkevich V; Tilanus HW; de Klein A; Dinjens WN
Genes Chromosomes Cancer; 2012 Mar; 51(3):272-82. PubMed ID: 22081516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
